Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Shares, $0.001 par value
-
Shares outstanding
-
104M
-
Number of holders
-
89
-
Total 13F shares, excl. options
-
29M
-
Shares change
-
+1.16M
-
Total reported value, excl. options
-
$476M
-
Value change
-
+$19M
-
Number of buys
-
37
-
Number of sells
-
-41
-
Price
-
$16.42
Significant Holders of BlackRock Health Sciences Term Trust - Common Shares, $0.001 par value (BMEZ) as of Q2 2023
97 filings reported holding BMEZ - BlackRock Health Sciences Term Trust - Common Shares, $0.001 par value as of Q2 2023.
BlackRock Health Sciences Term Trust - Common Shares, $0.001 par value (BMEZ) has 89 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 29M shares
of 104M outstanding shares and own 27.92% of the company stock.
Largest 10 shareholders include Saba Capital Management, L.P. (6.52M shares), MORGAN STANLEY (5.1M shares), BANK OF AMERICA CORP /DE/ (2.54M shares), UBS Group AG (2.08M shares), RIVERNORTH CAPITAL MANAGEMENT, LLC (1.64M shares), 1607 Capital Partners, LLC (1.58M shares), Invesco Ltd. (1.56M shares), WELLS FARGO & COMPANY/MN (1.04M shares), Karpus Management, Inc. (857K shares), and RAYMOND JAMES & ASSOCIATES (779K shares).
This table shows the top 89 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.